The development of the disease was indicated by the accumulation of an increased number of CD5+B220low CLL B cells in the spleen of the mouse in combination with splenomegaly (Figures 2A, C, D). This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.